Artemis Hospitals
The average sarcoma treatment cost in India typically involves complex diagnosis of sarcoma starting at AUD $2,857 to AUD $5,000 and sarcoma surgery ranging from AUD $10,714 to AUD $19,999. Total expenses depend on the cancer stage and treatment modality, with savings of around 60–80% compared to Australia and the US. Most patients find the highest standards of care in major medical hubs like Mumbai, Delhi, and Gurgaon.
Typical Sarcoma Treatment Costs in India
Bookimed Expert Insight: Patients with rare cases benefit from specialists like Dr. Raj Nagarkar. He has performed over 50,000 surgeries across 19 years. For advanced tumor targeting, Global Hospital Chennai uses linear accelerators for 1mm precision. If choosing between providers, Manipal Goa Hospital offers IBM Watson technology. This helps doctors select the most effective cancer treatment protocols for each patient.
| India | Thailand | Turkey | |
| Sarcoma surgery | from AUD $10,714 | from AUD $42,855 | from AUD $14,285 |
| Proton-beam therapy | from AUD $35,713 | from AUD $128,566 | from AUD $99,996 |
| High intensity focused ultrasound ablation (HIFU) | from AUD $6,000 | from AUD $12,142 | from AUD $5,714 |
| Chemotherapy for breast cancer | from AUD $5,000 | from AUD $4,286 | from AUD $1,714 |
No hidden fees – just official clinic prices. Pay at the clinic for Sarcoma treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Sarcoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Sarcoma treatment journey.
Dr Shaunak Valame is a dedicated medical oncologist at HCG Manavata Cancer Centre with specific training in managing complex tumours through Indraprastha Apollo Hospital.
Professor Sridhar P.S. is a senior radiation oncologist at HCG Manavata Cancer Centre specialising in targeted therapy for complex tumours.
The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.
Limbs can be saved in up to 95% of bone sarcoma cases in India. Surgeons use Limb Salvage Surgery to achieve these high preservation rates. They remove tumours while maintaining structural integrity. Teams use modular prostheses and 3D-printed implants to preserve function in arms and legs.
Bookimed Expert Insight: Patient volume often dictates technical mastery in salvage cases. Manipal Hospitals serves 2,000,000 patients annually. This scale allows surgical teams to handle rare anatomical reconstructions. When saving a limb, choosing these high-volume facilities often leads to better functional results.
Patient Consensus: Patients in India recommend seeking a second opinion before accepting amputation. They note that recovery usually feels more positive than losing a limb entirely, even with reduced function.
Sarcoma treatment in India is effective for metastatic disease through a multidisciplinary approach. Major centres use proton-beam therapy, robotic surgery, and targeted systemic therapies. Success depends on the specific sarcoma type and spread. Specialist teams manage cases with PET-CT diagnostics and precise radiotherapy.
Bookimed Expert Insight: Indian oncology centres often offer high-density nuclear medicine capabilities. Dr. Chaitainya Borde at HCG Manavata has managed 30,000+ PET scans. This volume suggests that clinics there have deep experience in tracking metastatic spread. Accurate staging through such experience is vital for planning effective systemic therapy.
Patient Consensus: Patients note it is important to clarify if the treatment goal is disease control or symptom relief in India. Finding a dedicated sarcoma multidisciplinary team matters more than general oncology services.
Sarcoma treatment in India typically begins 1 to 2 weeks after the first specialist consultation. Major oncology hubs expedite aggressive cases within days of a confirmed diagnosis. JCI-accredited facilities in Delhi and Bengaluru streamline care through multidisciplinary tumour board reviews and on-site diagnostic laboratories.
Bookimed Expert Insight: Patients can reduce wait times by providing pathology slides and digital imaging files before arrival. Clinics like Manipal Hospitals use IBM Watson for clinical decision support. This helps specialists cross-reference complex sarcoma data faster. This preparation often allows doctors to move straight to treatment planning rather than repeating basic diagnostics.
Patient Consensus: Patients note that treatment starts quicker when arriving with complete records. Bringing original biopsy slides for Indian pathology reviews prevents delays and avoids the need for repeat biopsies.
Sarcoma treatment in India typically lasts from 3 weeks to 12 months. Soft tissue sarcomas often require 3 weeks to 3 months. Bone sarcomas, including Ewing’s sarcoma, generally follow longer protocols spanning 9 to 12 months. The specific timeline depends on the cancer subtype and stage.
Bookimed Expert Insight: Indian centres like Manipal Hospitals and Apollo Hospital Indraprastha treat many international patients. Their high volume allows for rapid diagnostic turnaround. While bone sarcoma protocols are long, patients may return to Australia between chemotherapy cycles. This flexible approach is common at JCI-accredited facilities in Gurgaon and Bengaluru.
Patient Consensus: Patients note that sarcoma care in India is multi-stage and highly variable. Many recommend asking for a full timeline including recovery gaps. This is because chemotherapy cycles extend the duration well beyond the initial surgery.
Australian patients should look for Indian centres with Joint Commission International (JCI) accreditation. They should also seek a dedicated sarcoma multidisciplinary team. Priority should be given to hospitals offering limb-sparing surgery. Patients should check for PET-CT diagnostics and surgeons with high-volume experience in tumours.
Bookimed Expert Insight: Patients should focus on hospitals that combine high surgical volume with deep diagnostic infrastructure. For example, Manipal Hospitals serves 2,000,000 patients annually and uses IBM Watson for oncology. This scale often means the facility manages rare sarcoma subtypes more frequently than smaller clinics. Selecting a centre with an on-site research complex, such as Medanta, can provide faster staging protocols.
Patient Consensus: Patients emphasise the need for expert pathology re-reviews in India. This helps to ensure the sarcoma subtype is correctly identified before surgery. They suggest confirming the clinic provides digital records and pathology blocks. This makes the handover to Australian specialists seamless.